[Surgical tumor reduction in extensive ovarian cancer].
The value of radical resected residual tumors and the involvement of the lymph nodes are discussed on a series of 206 patients with ovarian carcinoma. The following results were achieved: macroscopically no tumor 100 patients; residual tumors smaller than 2 cm 14 patients, residual tumors larger than 3 cm 92 patients. Different chemotherapies were also applied. The survival rate of these groups after 2 years was as follows: 80.5%, 85.7%, 38.6%. After 5 years: 58.7%, 0%, 13.1%. In 48 patients after radical surgery and lymphadenectomy who had no post-operative residual tumors the survival rate was 100%, depending on the involvement of the lymph nodes.
D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D009367:Neoplasm Staging; D009852:Omentum / Q000601:surgery; D010051:Ovarian Neoplasms / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy; D011183:Postoperative Complications / Q000401:mortality
Die operative Tumorreduktion beim ausgedehnten Ovarialkarzinom.